🇮🇳 Lymphostat B in India

Lymphostat B (BELIMUMAB) regulatory status in India.

Marketing authorisation

CDSCO

  • Status: likely_approved

Lymphostat B in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in India

Frequently asked questions

Is Lymphostat B approved in India?

Yes. CDSCO has authorised it.

Who is the marketing authorisation holder for Lymphostat B in India?

Human Genome Sciences Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.